Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025)
Benitec Biopharma (BNTC) reported Enterprise Value of -$188.9 million for Q4 2025, down 141.11% on a YoY basis from $459.5 million in Q4 2024, and down 99.7% sequentially from -$94.6 million in Q3 2025.
Benitec Biopharma (BNTC) Enterprise Value (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Enterprise Value data on file, last reported at -$188.9 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 141.11% year-over-year to -$188.9 million; the trailing twelve-month figure through Dec 2025 stood at -$188.9 million (down 141.11% YoY), and the FY2025 full-year result was -$97.9 million, down 92.14% from the prior year.
- Enterprise Value declined to -$188.9 million in Q4 2025, from -$94.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13000.0 in Q1 2024 to a low of -$188.9 million in Q4 2025.
- A 5-year average of -$41.9 million and a median of -$18.1 million in 2021 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value soared 99.8% in 2024 and sank 796692.31% in 2025, its largest moves.
- Tracing BNTC's Enterprise Value over 5 years: stood at -$12.3 million in 2021, then advanced by 14.42% to -$10.6 million in 2022, then plunged by 93.23% to -$20.4 million in 2023, then tumbled by 284.27% to -$78.3 million in 2024, then sank by 141.11% to -$188.9 million in 2025.
- Business Quant data shows BNTC's Enterprise Value at -$188.9 million in Q4 2025, -$94.6 million in Q3 2025, and -$97.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | -188.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -188.90 Mn |
| Sep 30, 2025 | -94.59 Mn |
| Jun 30, 2025 | -97.86 Mn |
| Mar 31, 2025 | -103.58 Mn |
| Dec 31, 2024 | -78.35 Mn |
| Sep 30, 2024 | -67.86 Mn |
| Jun 30, 2024 | -50.93 Mn |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | -20.39 Mn |
| Sep 30, 2023 | -25.88 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -6.61 Mn |
| Dec 31, 2022 | -10.55 Mn |
| Sep 30, 2022 | -16.51 Mn |
| Jun 30, 2022 | -4.08 Mn |
| Mar 31, 2022 | -8.63 Mn |
| Dec 31, 2021 | -12.33 Mn |
| Sep 30, 2021 | -15.70 Mn |
| Jun 30, 2021 | -19.78 Mn |
| Mar 31, 2021 | -11.99 Mn |